GlassScriptPhysician profile
Jonathan P Riley
NPI 1346483039
$23,333.87
in general payments reported to CMS, 2019-2025
26 companies · $1,422 in 2025
The $1,422 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,211 · 2020: $6,360 · 2021: $5,130 · 2022: $1,175 · 2023: $4,253 · 2024: $2,783 · 2025: $1,422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,922 · Food and Beverage: $3,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,921.72 |
| Food and Beverage | $3,536.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clearpoint Neuro, INC. | $5,502.58 | 2023-2025 | Clearpoint |
| Integra Lifesciences Corporation | $4,963.95 | 2019-2021 | |
| Abbott Laboratories | $3,936.55 | 2019-2025 | Axium, Infinity, Proclaim |
| Nevro Corp. | $3,040.02 | 2019-2024 | Senza |
| Ptc Therapeutics, INC. | $2,437.50 | 2020-2021 | |
| Medtronic, INC. | $995.04 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Medtronic USA, INC. | $926.05 | 2019-2020 | |
| Boston Scientific Corporation | $587.22 | 2019-2025 | General - Dbs, Wavewriter Alpha Prime 16 |
| Neuropace, INC. | $179.15 | 2024-2025 | |
| Smith+Nephew, INC. | $154.78 | 2021 | |
| Globus Medical, INC. | $120.42 | 2022-2025 | Senza, Excelsiusgps Robotic Navigation System |
| Pfizer INC. | $99.68 | 2019-2025 | |
| Stryker Corporation | $90.21 | 2022 | |
| Saluda Medical Americas, INC. | $62.39 | 2024-2025 | Evoke |
| Arteriocyte Medical Systems, INC. | $34.54 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $28.84 | 2025 | Celleraterx |
| Longeviti Neuro Solutions INC | $26.28 | 2025 | Clearfit |
| Mml US, INC. | $25.75 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $21.12 | 2023 | Sprint Pns System |
| Livanova USA, INC. | $19.49 | 2023 | Vns Therapy Symmetry Model 8103 Generator |
| Solventum Corporation | $18.71 | 2025 | Prevena |
| Amgen INC. | $18.49 | 2024 | Prolia, Evenity |
| Si-Bone, INC. | $15.79 | 2023 | |
| Nalu Medical, INC. | $15.53 | 2021 | |
| Orthofix Medical, INC. | $13.79 | 2025 | Spinal-Stim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.